CC-90002-ST-001

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCC-90002-ST-001
Drug Alias NameCC-90002-ST-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionCluster of differentiation 47 inhibitors
TargetsCluster of differentiation 47
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Centre Of Monoclonal Therapy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Centre Of Monoclonal Therapy
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A